VanEck Pharmaceutical ETF Rating $88.96 -0.46 (-0.51%) Closing price 03:59 PM EasternExtended Trading$89.02 +0.06 (+0.06%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsTrendsBuy This Stock VanEck Pharmaceutical ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PPH Aggregate RatingModerate Buy 2.58Holdings in PPH have an aggregate rating of Moderate Buy based on 274 analyst ratings issued in the past year covering 22 companies (92.0% of the portfolio).PPH Aggregate Price Target$89.060.11% UpsideHigh Prediction$89.06Average Prediction$89.06Low Prediction$89.06Holdings in PPH have an aggregate price target of $89.06 and a range of $89.06 to $89.06 covering 22 companies (92.0% of the portfolio).PPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Pharmaceutical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 PPH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings16.70%LLYEli Lilly and Company$742.22+0.6%5 of 5 stars2.67$950.17 28.0%24Trending NewsAnalyst Revision11.60%JNJJohnson & Johnson$178.64+0.4%4.6133 of 5 stars2.65$176.29 -1.3%20Positive News6.28%MRKMerck & Co., Inc.$83.96-0.3%4.9971 of 5 stars2.35$107.44 28.0%20Positive News6.00%NVONovo Nordisk A/S$56.15-1.0%4.3667 of 5 stars2.13$81.00 44.3%16Trending News5.00%ABBVAbbVie$212.77+0.4%4.7026 of 5 stars2.92$214.95 1.0%26Trending News4.99%AZNAstraZeneca$81.78-0.4%2.4659 of 5 stars2.80$86.00 5.2%5Positive News4.81%PFEPfizer$24.51-1.1%4.8448 of 5 stars2.39$28.12 14.7%18Trending News4.66%SNYSanofi$45.33-9.2%3.8565 of 5 stars3.22$62.00 36.8%9Trending NewsAnalyst UpgradeShort Interest ↑Gap DownHigh Trading Volume4.50%MCKMcKesson$691.03+0.0%4.5018 of 5 stars2.85$725.10 4.9%13Positive NewsAnalyst Revision4.41%BMYBristol Myers Squibb$46.65-1.8%4.5685 of 5 stars2.24$56.38 20.8%21Positive NewsInsider TradeAnalyst Revision4.40%GSKGSK$39.55+0.5%2.719 of 5 stars1.86$37.38 -5.5%7Dividend CutAnalyst Revision4.28%ZTSZoetis$153.13+0.5%4.768 of 5 stars2.50$202.43 32.2%8Positive News3.88%CORCencora$292.77-0.8%4.4546 of 5 stars2.75$311.25 6.3%12Positive NewsAnalyst Revision3.42%HLNHaleon$9.85-0.5%3.9942 of 5 stars2.78$12.33 25.2%9Positive News2.92%TAKTakeda Pharmaceutical$15.30+1.0%2.797 of 5 stars2.002Positive News1.76%TEVATeva Pharmaceutical Industries$18.53-1.3%3.3964 of 5 stars3.25$24.71 33.4%8News CoveragePositive News0.77%VTRSViatris$10.33-2.1%1.7973 of 5 stars1.80$10.40 0.7%50.52%JAZZJazz Pharmaceuticals$127.93-2.9%4.6982 of 5 stars2.88$178.67 39.7%16Positive News0.41%ELANElanco Animal Health$17.47+0.7%3.1085 of 5 stars2.78$17.33 -0.8%9Analyst Revision0.31%AXSMAxsome Therapeutics$124.50+2.0%4.7788 of 5 stars3.13$177.86 42.9%15News CoveragePositive NewsAnalyst ForecastInsider Trade0.18%PRGOPerrigo$23.27-0.3%4.9253 of 5 stars2.40$33.00 41.8%5News CoverageAnalyst Revision0.16%OGNOrganon & Co.$9.67-1.6%4.8339 of 5 stars2.50$18.00 86.1%6 This page (NASDAQ:PPH) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersMusk Warns. Trump Acts. Your Retirement May Depend on ItWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredDid you spot this in the Oval Office last week?When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Pharmaceutical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PPH Stock Alerts